基于移动纳米机器的血管内异常检测
Abnormality Detection inside Blood Vessels with Mobile Nanomachines
摘要:
受生物纳米物联网(IoBNT)中分子通信的众多医疗保健应用的启发,这项工作解决了使用称为协作生物纳米机器(CN)的多个生物嵌入式计算设备和称为融合中心(FC)的公共接收器进行血管异常检测的问题。由于血管内的血液流动,假设每个CN和FC是移动的。在这项工作中,每个CN通过对从源接收的分子的数量进行计数来执行具有一定检测概率和错误警报的异常检测,例如,感染的组织这些氯化萘随后在存在符号间干扰、多源干扰和计数误差的情况下,使用不同类型的分子,通过扩散-平流血流通道向FC报告其局部决定。由于有限的计算能力在FC,或和逻辑为基础的融合规则进行最后的决定后,获得每个本地决策的基础上的最佳似然比测试。对于上述系统,在FC的检测和虚警概率推导或和与融合规则。最后,仿真结果验证了推导的分析结果,这提供了重要的见解。
英文摘要:
Motivated by the numerous healthcare applications of molecular communication within Internet of Bio-Nano Things (IoBNT), this work addresses the problem of abnormality detection in a blood vessel using multiple biological embedded computing devices called cooperative biological nanomachines (CNs), and a common receiver called the fusion center (FC). Due to blood flow inside a vessel, each CN and the FC are assumed to be mobile. In this work, each of the CNs perform abnormality detection with certain probabilities of detection and false alarm by counting the number of molecules received from a source, e.g., infected tissue. These CNs subsequently report their local decisions to a FC over a diffusion-advection blood flow channel using different types of molecules in the presence of inter-symbol interference, multi-source interference, and counting errors. Due to limited computational capability at the FC, OR and AND logic based fusion rules are employed to make the final decision after obtaining each local decision based on the optimal likelihood ratio test. For the aforementioned system, probabilities of detection and false alarm at the FC are derived for OR and AND fusion rules. Finally, simulation results are presented to validate the derived analytical results, which provide important insights.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。